Rodgers Brothers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,781
| Closed | -$301K | – | 233 |
|
|
2024
Q3 | $301K | Buy |
+4,781
| New | +$279K | 0.04% | 207 |
|
|
2024
Q2 | – | Sell |
-23,306
| Closed | -$1.86M | – | 245 |
|
|
2024
Q1 | $1.86M | Sell |
23,306
-4,805
| -17% | -$367K | 0.25% | 101 |
|
|
2023
Q4 | $2.22M | Sell |
28,111
-900
| -3% | -$64.1K | 0.35% | 80 |
|
|
2023
Q3 | $2.03M | Sell |
29,011
-300
| -1% | -$21.3K | 0.35% | 80 |
|
|
2023
Q2 | $2.03M | Buy |
29,311
+2,100
| +8% | +$149K | 0.36% | 79 |
|
|
2023
Q1 | $2.02M | Buy |
27,211
+22,825
| +520% | +$1.91M | 0.39% | 70 |
|
|
2022
Q4 | $409K | Hold |
4,386
| – | – | 0.08% | 164 |
|
|
2022
Q3 | $418K | Sell |
4,386
-230
| -5% | -$22.8K | 0.09% | 167 |
|
|
2022
Q2 | $428K | Hold |
4,616
| – | – | 0.08% | 165 |
|
|
2022
Q1 | $467K | Hold |
4,616
| – | – | 0.08% | 159 |
|
|
2021
Q4 | $476K | Sell |
4,616
-72
| -2% | -$6.65K | 0.08% | 170 |
|
|
2021
Q3 | $398K | Hold |
4,688
| – | – | 0.08% | 168 |
|
|
2021
Q2 | $391K | Sell |
4,688
-24,760
| -84% | -$2.03M | 0.07% | 169 |
|
|
2021
Q1 | $2.21M | Sell |
29,448
-2,400
| -8% | -$175K | 0.46% | 62 |
|
|
2020
Q4 | $2.17M | Sell |
31,848
-600
| -2% | -$39K | 0.5% | 57 |
|
|
2020
Q3 | $1.9M | Buy |
32,448
+8,927
| +38% | +$555K | 0.49% | 56 |
|
|
2020
Q2 | $1.53M | Buy |
23,521
+154
| +0.7% | +$9.7K | 0.41% | 61 |
|
|
2020
Q1 | $1.39M | Buy |
23,367
+404
| +2% | +$27K | 0.44% | 61 |
|
|
2019
Q4 | $1.71M | Sell |
22,963
-184
| -0.8% | -$12.9K | 0.44% | 60 |
|
|
2019
Q3 | $1.46M | Sell |
23,147
-1,525
| -6% | -$90.4K | 0.4% | 66 |
|
|
2019
Q2 | $1.34M | Buy |
24,672
+1,404
| +6% | +$75.6K | 0.37% | 70 |
|
|
2019
Q1 | $1.25M | Buy |
23,268
+15,128
| +186% | +$934K | 0.36% | 68 |
|
|
2018
Q4 | $533K | Sell |
8,140
-50
| -0.6% | -$3.73K | 0.17% | 109 |
|
|
2018
Q3 | $645K | Buy |
8,190
+50
| +0.6% | +$3.58K | 0.19% | 104 |
|
|
2018
Q2 | $524K | Buy |
8,140
+2,200
| +37% | +$145K | 0.16% | 117 |
|
|
2018
Q1 | $370K | Buy |
5,940
+2,209
| +59% | +$158K | 0.12% | 132 |
|
|
2017
Q4 | $270K | Sell |
3,731
-534
| -13% | -$38.8K | 0.09% | 152 |
|
|
2017
Q3 | $347K | Hold |
4,265
| – | – | 0.12% | 133 |
|
|
2017
Q2 | $343K | Buy |
4,265
+800
| +23% | +$63.2K | 0.13% | 133 |
|
|
2017
Q1 | $272K | Buy |
+3,465
| New | +$277K | 0.1% | 141 |
|
Other funds holding CVS
Rodgers Brothers's CVS Position: Q4 2024 in Review
Rodgers Brothers sold out of CVS Health (CVS) in Q4 2024, closing a stake of 4,781 shares — an estimated $301K sold.
Rodgers Brothers first reported a position in CVS in Q1 2017 and held it in 30 quarters. The position peaked at $2.22M in Q4 2023. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Rodgers Brothers reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- Rodgers Brothers sold 4,781 CVS Health shares in Q4 2024, an estimated $301K.
- Rodgers Brothers first reported a position in CVS Health in Q1 2017 and held it in 30 quarters.
- Rodgers Brothers's CVS Health position peaked at $2.22M in Q4 2023.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Rodgers Brothers's 13F filing for Q4 2024, filed 12 Feb 2025.